Clinical Trial Update: To Evaluate the Efficacy and Safety of Anlotinib Hydrochloride Capsule in Postoperative Non-pCR Patients With Non-small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the efficacy and safety of Anlotinib hydrochloride capsule in postoperative non-pCR patients with non-small cell lung cancer i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Anlotinib hydrochloride capsule (Anlotinib hydrochloride)

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: Non-Small Cell Lung Cancer | Phase 2 | Status: RECRUITING